Evidence map›Paper›PMID 41195201›Full record

ArticleTransplant international : official journal of the European Society for Organ Transplantation2025

cDCDD and Heart Procurement: Challenges from a French Critical Care Perspective.

Matthieu Le Dorze, Julien Charpentier, Gaëlle Cheisson, David Couret, Guillaume Ducos, Benjamin Zuber

Abstract read
In one paragraph

Article in Transplant international : official journal of the European Society for Organ Transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Modeling the cost-effectiveness of introducing donation after controlled circulatory death for heart transplantation in France.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matthieu Le DorzeUniversité Paris Cité, INSERM U942 MASCOT, Paris, France.
Julien CharpentierService de médecine intensive-réanimation, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France.
Gaëlle CheissonDepartment of Anaesthesia and Intensive Care Medicine, Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France.
David CouretNeurocritical Care Unit, University Hospital Saint Pierre, Réunion University, Saint Denis de La Réunion, France.
Guillaume DucosDepartment Bioethics, CERPOP, UMR 1295, Inserm - Université de Toulouse: "Trajectoires d'innovations en santé: enjeux bioéthiques et sociétaux", Toulouse, France.
Benjamin ZuberMedical Intensive Care Unit, Hôpital Foch, Suresnes, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Controlled donation after the circulatory determination of death (cDCDD) is currently one of the most promising ways to increase organ availability. In France, a national cDCDD protocol requiring abdominal normothermic regional perfusion (A-NRP) has been in place since 2015. The recent consideration of heart procurement from cDCDD donors has reignited clinical and ethical debates within the critical care community. This position paper, endorsed by the two French intensive care societies, provides a critical care perspective on this evolving practice. Two key challenges are identified. First, heart procurement may require the withdrawal of life-sustaining measures (WLSM) to occur in or near the operating room, in contrast with French current practice where WLSM mostly takes place in the ICU. Intensivists strongly advocate maintaining ICU-based WLSM whenever possible, and ensuring continuity of care and end-of-life support when relocation is unavoidable. Second, the use of NRP raises concerns about the permanence of death and compliance with the dead donor rule. These concerns can be addressed through targeted biomedical research and a robust ethical framework affirming that death is declared prior to NRP and that no return to life is possible thereafter. Transparent engagement with these challenges is essential to sustain trust in the cDCDD pathway.

Indexed as

DeathTissue and Organ ProcurementContinuity of Patient CareCritical CareFranceHeart TransplantationHumansIntensive Care UnitsTerminal CareTissue DonorsWithholding Treatmentcontrolled donation after circulatory deathdead donor ruleend-of-life careheart procurementnormothermic regional perfusion

Identifiers

PMID41195201
PMCPMC12583100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.